Letitia E Bible1, Latha V Pasupuleti1, Amy V Gore1, Ziad C Sifri1, Kolenkode B Kannan2, Alicia M Mohr3. 1. Department of Surgery, Division of Trauma, Rutgers-New Jersey Medical School, Newark, NJ. 2. Department of Surgery, Division of Acute Care Surgery, University of Florida, Gainesville, FL. 3. Department of Surgery, Division of Acute Care Surgery, University of Florida, Gainesville, FL. Electronic address: alicia.mohr@surgery.ufl.edu.
Abstract
INTRODUCTION: Propranolol has been shown previously to decrease the mobilization of hematopoietic progenitor cells (HPCs) after acute injury in rodent models; however, this acute injury model does not reflect the prolonged period of critical illness after severe trauma. Using our novel lung contusion/hemorrhagic shock/chronic restraint stress model, we hypothesize that daily administration of propranolol will decrease prolonged mobilization of HPCs without worsening lung healing. METHODS: Male Sprague-Dawley rats underwent 6 days of restraint stress after undergoing lung contusion or lung contusion/hemorrhagic shock. Restraint stress consisted of a daily 2-hour period of restraint interrupted every 30 minutes by alarms and repositioning. Each day after the period of restraint stress, the rats received intraperitoneal propranolol (10 mg/kg). On day 7, peripheral blood was analyzed for granulocyte-colony stimulating factor (G-CSF) and stromal cell-derived factor 1 via enzyme-linked immunosorbent assay and for mobilization of HPCs using c-kit and CD71 flow cytometry. The lungs were examined histologically to grade injury. RESULTS: Seven days after lung contusion and lung contusion/hemorrhagic shock, the addition of chronic restraint stress significantly increased the mobilization of HPC, which was associated with persistently increased levels of G-CSF and increased lung injury scores. The addition of propranolol to lung contusion/chronic restraint stress and lung contusion/hemorrhagic shock/chronic restraint stress models greatly decreased HPC mobilization and restored G-CSF levels to that of naïve animals without worsening lung injury scores. CONCLUSION: The daily administration of propranolol after both lung contusion and lung contusion/hemorrhagic shock subjected to chronic restraint stress decreased the prolonged mobilization of HPC from the bone marrow and decreased plasma G-CSF levels. Despite the decrease in mobilization of HPC, lung healing did not worsen. Alleviating chronic stress with propranolol may be a future therapeutic target to improve healing after severe injury.
INTRODUCTION:Propranolol has been shown previously to decrease the mobilization of hematopoietic progenitor cells (HPCs) after acute injury in rodent models; however, this acute injury model does not reflect the prolonged period of critical illness after severe trauma. Using our novel lung contusion/hemorrhagic shock/chronic restraint stress model, we hypothesize that daily administration of propranolol will decrease prolonged mobilization of HPCs without worsening lung healing. METHODS: Male Sprague-Dawley rats underwent 6 days of restraint stress after undergoing lung contusion or lung contusion/hemorrhagic shock. Restraint stress consisted of a daily 2-hour period of restraint interrupted every 30 minutes by alarms and repositioning. Each day after the period of restraint stress, the rats received intraperitoneal propranolol (10 mg/kg). On day 7, peripheral blood was analyzed for granulocyte-colony stimulating factor (G-CSF) and stromal cell-derived factor 1 via enzyme-linked immunosorbent assay and for mobilization of HPCs using c-kit and CD71 flow cytometry. The lungs were examined histologically to grade injury. RESULTS: Seven days after lung contusion and lung contusion/hemorrhagic shock, the addition of chronic restraint stress significantly increased the mobilization of HPC, which was associated with persistently increased levels of G-CSF and increased lung injury scores. The addition of propranolol to lung contusion/chronic restraint stress and lung contusion/hemorrhagic shock/chronic restraint stress models greatly decreased HPC mobilization and restored G-CSF levels to that of naïve animals without worsening lung injury scores. CONCLUSION: The daily administration of propranolol after both lung contusion and lung contusion/hemorrhagic shock subjected to chronic restraint stress decreased the prolonged mobilization of HPC from the bone marrow and decreased plasma G-CSF levels. Despite the decrease in mobilization of HPC, lung healing did not worsen. Alleviating chronic stress with propranolol may be a future therapeutic target to improve healing after severe injury.
Authors: Yoshio Katayama; Michela Battista; Wei-Ming Kao; Andrés Hidalgo; Anna J Peired; Steven A Thomas; Paul S Frenette Journal: Cell Date: 2006-01-27 Impact factor: 41.582
Authors: Jean Pierre Lévesque; Jean Hendy; Yasushi Takamatsu; Brenda Williams; Ingrid G Winkler; Paul J Simmons Journal: Exp Hematol Date: 2002-05 Impact factor: 3.084
Authors: Ruth B S Harris; Tiffany D Mitchell; Jacob Simpson; Stephen M Redmann; Bradley D Youngblood; Donna H Ryan Journal: Am J Physiol Regul Integr Comp Physiol Date: 2002-01 Impact factor: 3.619
Authors: Peter Vargovic; Jozef Ukropec; Marcela Laukova; Timea Kurdiova; Miroslav Balaz; Bernhard Manz; Barbara Ukropcova; Richard Kvetnansky Journal: Stress Date: 2012-11-12 Impact factor: 3.493
Authors: Xiao-Jun Zhang; Chengyue Meng; David L Chinkes; Celeste C Finnerty; Asle Aarsland; Marc G Jeschke; David N Herndon Journal: Surgery Date: 2009-03-21 Impact factor: 3.982
Authors: Jeffrey L Voorhees; Andrew J Tarr; Eric S Wohleb; Jonathan P Godbout; Xiaokui Mo; John F Sheridan; Timothy D Eubank; Clay B Marsh Journal: PLoS One Date: 2013-03-08 Impact factor: 3.240
Authors: Getasha D Doobay; Elizabeth S Miller; Camille G Apple; Tyler J Loftus; Kolenkode B Kannan; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2020-12-26 Impact factor: 2.192
Authors: Tyler J Loftus; Andrew J Thomson; Kolenkode B Kannan; Ines G Alamo; Jessica K Millar; Jessica M Plazas; Elizabeth E Whitley; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2017-06-23 Impact factor: 2.565
Authors: Jessica K Millar; Kolenkode B Kannan; Tyler J Loftus; Ines G Alamo; Jessica Plazas; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2017-03-31 Impact factor: 2.192
Authors: Ines G Alamo; Kolenkode B Kannan; Letitia E Bible; Tyler J Loftus; Harry Ramos; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2017-04 Impact factor: 3.313
Authors: Ines G Alamo; Kolenkode B Kannan; Harry Ramos; Tyler J Loftus; Philip A Efron; Alicia M Mohr Journal: Surgery Date: 2016-10-11 Impact factor: 3.982
Authors: Elizabeth S Miller; Tyler J Loftus; Kolenkode B Kannan; Jessica M Plazas; Philip A Efron; Alicia M Mohr Journal: J Surg Res Date: 2019-06-14 Impact factor: 2.192
Authors: Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr Journal: J Trauma Acute Care Surg Date: 2018-03 Impact factor: 3.313
Authors: Tyler J Loftus; Kolenkode B Kannan; Christy S Carter; Jessica M Plazas; Juan C Mira; Scott C Brakenridge; Christiaan Leeuwenburgh; Philip A Efron; Alicia M Mohr Journal: Exp Gerontol Date: 2018-01-04 Impact factor: 4.032
Authors: Elizabeth S Miller; Camille G Apple; Kolenkode B Kannan; Zackary M Funk; Philip A Efron; Alicia M Mohr Journal: Am J Surg Date: 2020-07-25 Impact factor: 2.565